HALIFAX, Jan. 5 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,
NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and
solutions, today announced that the Board of Directors granted a total of
1,585,000 options to purchase commons shares to its employees. Of this total,
450,000 options were issued to officers and managing directors. The options
are at an exercise prices of $0.10 per share and are exercisable for a period
of five years. The grant is subject to the approval of the TSX Venture
Exchange.
